Education
About Us
Working with TipRanks
Follow Us
Surgery Partners Inc (SGRY)
NASDAQ:SGRY
SGRY Stock Chart & Stats
Day’s Range― - ―
52-Week Range$19.50 - $33.97
Previous CloseN/A
Volume149.01K
Average Volume (3M)973.89K
Market Cap
$2.79B
Enterprise Value$7.95B
Total Cash (Recent Filing)$74.92M
Total Debt (Recent Filing)$1.41B
Price to Earnings (P/E)―
Beta1.37
Next Earnings
May 12, 2025EPS Estimate
0.07Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.33
Shares Outstanding127,613,090
10 Day Avg. Volume1,045,538
30 Day Avg. Volume973,892
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.99
Price to Cash Flow (P/CF)6.90
P/FCF Ratio17.90
Enterprise Value/Market Cap2.85
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.66
Enterprise Value/Ebitda15.86
Forecast
1Y Price Target
$32.00Price Target Upside46.52% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering10
---
Surgery Partners News
PremiumCompany Announcements
Surgery Partners Delays Annual Report Filing
PremiumCompany Announcements
Surgery Partners Reports Strong Revenue Growth for 2024---
Bulls Say, Bears Say
Bulls Say
Cash FlowCash flows from operations increased by 78% in the quarter to $111.4 million, indicating robust financial health.
EarningsSGRY reported strong Q4:24 results, with adjusted EPS of $0.44 beating consensus estimates by +22%.
Financial PerformanceSurgery Partners is positioned for strong margin and cash performance following extensive M&A capital deployment and integration activity.
Bears Say
CostsElevated integration costs from last year's above-normal M&A activity could impact margins in the first half.
EBITDA GuidanceThe mid-point of FY25 EBITDA guidance fell slightly short of the $566 million consensus, primarily due to a divestiture in Q4.
Revenue GuidanceThe company guided 2025 revenues in a range of $3.3-3.45 billion, or 3% below consensus at the midpoint.
---
Ownership Overview
1.39% Insiders
36.34% Mutual Funds
1.02% Other Institutional Investors
51.06% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
SGRY FAQ
What was Surgery Partners Inc’s price range in the past 12 months?
Surgery Partners Inc lowest stock price was $19.50 and its highest was $33.97 in the past 12 months.
What is Surgery Partners Inc’s market cap?
Surgery Partners Inc’s market cap is $2.79B.
When is Surgery Partners Inc’s upcoming earnings report date?
Surgery Partners Inc’s upcoming earnings report date is May 12, 2025 which is in 16 days.
How were Surgery Partners Inc’s earnings last quarter?
Surgery Partners Inc released its earnings results on Mar 03, 2025. The company reported $0.44 earnings per share for the quarter, beating the consensus estimate of $0.376 by $0.064.
Is Surgery Partners Inc overvalued?
According to Wall Street analysts Surgery Partners Inc’s price is currently Undervalued.
Does Surgery Partners Inc pay dividends?
Surgery Partners Inc does not currently pay dividends.
What is Surgery Partners Inc’s EPS estimate?
Surgery Partners Inc’s EPS estimate is 0.07.
How many shares outstanding does Surgery Partners Inc have?
Surgery Partners Inc has 127,613,090 shares outstanding.
What happened to Surgery Partners Inc’s price movement after its last earnings report?
Surgery Partners Inc reported an EPS of $0.44 in its last earnings report, beating expectations of $0.376. Following the earnings report the stock price went down -0.332%.
Which hedge fund is a major shareholder of Surgery Partners Inc?
Currently, no hedge funds are holding shares in SGRY
---
Surgery Partners Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$32.00 (46.52% Upside)
$32.00 (46.52% Upside)
Blogger Sentiment
Bullish
SGRY Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 2.8M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $3.5M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▼ 1.4%
Last 30 Days ▼ 1.4%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-14.35%
12-Months-Change
Fundamentals
Return on Equity
-8.90%
Trailing 12-Months
Asset Growth
14.10%
Trailing 12-Months
Company Description
Surgery Partners Inc
Surgery Partners, Inc. (SGRY) is a leading healthcare services company focused on providing high-quality surgical services across the United States. The company operates in the healthcare sector, specifically within the outpatient surgery and ancillary services market. Surgery Partners owns and operates a network of surgical facilities, including ambulatory surgery centers (ASCs) and surgical hospitals, offering a range of clinical services to patients. Their core services include outpatient surgeries, diagnostic services, and ancillary services such as anesthesia and pharmacy.
---
SGRY Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Surgery Partners demonstrated robust financial performance in 2024 with record revenue and EBITDA growth, driven by strong organic growth and strategic acquisitions. The company successfully managed contractual rates and expanded its physician base, positioning itself well for 2025. However, higher transaction costs impacted cash flow, and potential legislative changes pose a manageable risk. Overall, the highlights significantly outweigh the lowlights, underscoring a positive outlook.Read More>---
SGRY Stock 12 Month Forecast
Average Price Target
$32.00
▲(46.52% Upside)
Technical Analysis
Best Analysts Covering SGRY
1 Year
1 Year Success Rate
11/26 ratings generated profit
1 Year Average Return
+14.16%
reiterated a buy rating 2 months ago
Copying Brian Tanquilut's trades and holding each position for 1 Year would result in 42.31% of your transactions generating a profit, with an average return of +14.16% per trade.
---